Related Experiment Video
Updated: May 27, 2026
10:46
Generation of Airway Epithelial Cell Air-Liquid Interface Cultures from Human Pluripotent Stem Cells
Published on: June 14, 2022
Vascular progenitor cells in chronic obstructive pulmonary disease
Joan Albert Barberà1, Víctor I Peinado
1Department of Pulmonary Medicine, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain. jbarbera@clinic.ub.es
Proceedings of the American Thoracic Society
|November 5, 2011
Summary
Chronic obstructive pulmonary disease (COPD) is linked to fewer bone marrow-derived vascular progenitor cells, potentially impairing vascular repair and increasing cardiovascular risks. Further research is needed to understand these mechanisms for better COPD management.
Area of Science:
- Cardiovascular Research
- Pulmonary Medicine
- Cell Biology
Background:
- Chronic obstructive pulmonary disease (COPD) is associated with significant vascular changes.
- Pulmonary arteries in COPD often exhibit intimal hyperplasia, involving smooth muscle cell proliferation of undetermined origin.
- Bone marrow progenitor cells can differentiate into vascular cells, but their role in COPD vascular remodeling is unclear.
Purpose of the Study:
- To investigate the origin of smooth muscle cells in COPD-related vascular changes.
- To determine the number and role of circulating bone marrow-derived vascular progenitor cells in COPD.
- To understand the implications of altered progenitor cell populations for vascular repair and cardiovascular risk in COPD.
Main Methods:
- Analysis of vascular changes in pulmonary and systemic circulations in COPD patients.
- Assessment of circulating hemopoietic and vascular progenitor cell numbers.
- Review of literature on bone marrow progenitor cell differentiation and migration in vascular contexts.
Main Results:
- COPD is characterized by a reduction in circulating hemopoietic and vascular progenitor cells.
- The precise mechanisms driving this reduction in COPD are not yet understood.
- Bone marrow-derived progenitor cells can differentiate into smooth muscle cells within the vessel wall under specific conditions.
Conclusions:
- Reduced circulating vascular progenitor cells in COPD may impair vascular repair capacity.
- This reduction could contribute to the increased risk of cardiovascular complications in COPD patients.
- Further research into these mechanisms is crucial for improving COPD management and reducing associated mortality.
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.